Monitor for actual sales under this ATM program, as the filing itself is procedural. The small offering size suggests a need for capital but is not immediately dilutive unless fully utilized.
Price Chart
Executive Summary
InMed Pharmaceuticals filed a prospectus supplement to its shelf registration statement to sell up to $1,213,648 worth of common shares through an at-the-market offering with H.C. Wainwright & Co. This is a routine capital raise under an existing agreement.
Key Facts
- InMed Pharmaceuticals filed a prospectus supplement on April 3, 2026, to sell up to $1,213,648 of common shares.
- The offering is conducted through an at-the-market (ATM) agreement with H.C. Wainwright & Co., originally dated April 7, 2022, and amended June 27, 2024.
- The shares are being offered under a shelf registration statement (Form S-3, File No. 333-294503) declared effective on March 30, 2026.
- The filing includes a legal opinion confirming the legality of the securities being registered.
Financial Impact
Up to $1,213,648 in gross proceeds from the sale of common shares, representing a small potential dilution given the company's $2M market cap.
Risk Factors
- Potential share dilution if the full amount is sold.
- Downward pressure on stock price if sales occur in a weak market.
- Use of proceeds not specified, creating uncertainty about how funds will be deployed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-039943 |
| Document: ea028498901ex5-1.htm | 0001213900-26-039943 |
| Document: 0001213900-26-039943-index-headers.html | 0001213900-26-039943 |
| Document: 0001213900-26-039943-index.html | 0001213900-26-039943 |
| Document: 0001213900-26-039943.txt | 0001213900-26-039943 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 425 | $1.31 $1.39 | ▲ +6.11% | ▲ +6.61% | $1.33 (+1.53%) |
Jul 10, 2026 12w ago | 8-K | $1.57 $1.52 | ▲ +3.18% | ▲ +2.40% | $1.33 (+15.29%) |
Jul 2, 2026 13w ago | S-4 | $1.56 $1.66 | ▼ −6.41% | ▼ −5.48% | $1.33 (+14.74%) |
Jun 11, 2026 16w ago | Insider Cluster | $1.58 $1.49 | ▼ −5.70% | ▼ −6.13% | $1.33 (−15.82%) |
Jun 10, 2026 16w ago | 8-K | $1.51 $1.48 | ▼ −1.99% | ▼ −5.42% | $1.33 (−11.92%) |
May 19, 2026 19w ago | 425 | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.69 | ▲ +5.63% | ▲ +3.38% | $1.33 (−16.87%) |
May 19, 2026 19w ago | 8-K | $1.60 $1.66 | ▼ −3.75% | ▼ −1.45% | $1.33 (+16.87%) |
Apr 27, 2026 22w ago | 8-K | $0.7010 $0.7480 | ▼ −6.70% | ▼ −5.01% | $1.33 (−89.73%) |
Apr 3, 2026 26w ago | 8-K | $0.6950 $0.7130 | ▲ +2.59% | ▼ −1.54% | $1.33 (+91.37%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access